Association between time from diagnosis to initiation of systemic therapy of metastatic renal cell carcinoma with treatment outcome
Introduction: In about 30% of cases, renal cell carcinoma (RCC) is detected initially in the metastatic stage (mRCC). The mainstay of mRCC treatment is anti-angiogenesis targeted therapy and immunotherapy which both have significantly prolonged progression-free survival and overall survival in patie...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Belgrade, Medical Faculty
2023-01-01
|
Series: | Medicinski Podmladak |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/0369-1527/2023/0369-15272303064L.pdf |